[Translation] A multicenter, randomized, double-blind, placebo-controlled phase Ib study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of different concentrations of ZYG24004 in patients with dermatophyte-induced tinea pedis.
主要目的:评估不同浓度(1%、3%)ZYG24004在皮肤癣菌引起的足癣患者中单次或两次(每周一次,连续两周)外用后的安全性、局部耐受性及药代动力学特征。次要目的:探索ZYG24004在皮肤癣菌引起的足癣患者中的初步有效性。
[Translation] Primary objective: To evaluate the safety, local tolerability, and pharmacokinetic characteristics of different concentrations (1%, 3%) of ZYG24004 after single or double application (once a week for two consecutive weeks) in patients with dermatophyte-induced tinea pedis. Secondary objective: To explore the preliminary efficacy of ZYG24004 in patients with dermatophyte-induced tinea pedis.